💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

ANPD Readies Tomorrow's Nursing Professional Development Leaders With Wolters Kluwer EBP Workflow Solution

Published 2024-04-03, 09:14 a/m
WKL
-

Association for Nursing Professional Development implements Ovid Synthesis to support EBP and Leadership Academies

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that the Association for Nursing Professional Development (ANPD) has selected Ovid ® Synthesis to help support evidence-based practice (EBP), quality improvement (QI), and research for two key programs. Participants in the Nursing Professional Development (NPD) Leadership Academy and the Evidence-Based Practice Academy, as well as their mentors, will have full access to the Ovid Synthesis platform and its innovative workflow application.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240403110031/en/

The Association for Nursing Professional Development has selected the innovative workflow solution, Ovid ® Synthesis, to help support evidence-based practice, quality improvement for their Nursing Professional Development Leadership Academy and the Evidence-Based Practice Academy. (Photo: Business Wire)

An essential solution for nursing professional development

ANPD and Wolters Kluwer share a vision for developing healthcare leaders and practitioners that make a real impact on patient lives. This collaboration ensures nurses who enroll in ANPD's academies are grounding their skills in evidence-based practice through leading-edge workflow solutions, said Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health. As the publisher of ANPD's research publication, the Journal for Nurses in Professional Development, we are excited to add this new offering to our long-standing relationship.

ANPD academy programs focus on advancing the specialty practice of nursing professional development. The organization serves as an expert voice, advocate, and leading resource for NPD. With evidence-based standards for professional development, NPD plays an essential role in quality, organizational, and patient outcomes.

Ovid Synthesis offers ANPD academies with trustworthy, EBP workflow applications to promote a culture of clinical inquiry and innovation, as well as collaborative education and practice among participants and mentors. The AI-enabled technology allows NPD professionals to seamlessly work through and implement system-wide EBP initiatives to fuel exceptional nursing care for every individual.

Streamlining evidence-based practice

At ANPD we have over 7,500 members eager for innovative tools. Ovid Synthesis bridges the EBP theory-to-practice gap, streamlines the process from PICOT question to project completion, and empowers users to lead, using the most current evidence, said Sheila St. Cyr, MS, RN, NPD-BC, President of ANPD. We look forward to jumpstarting our year-long academies with Ovid Synthesis at this year's ANPD Aspire Convention.

For the past 30 years, the Association for Nursing Professional Development (ANPD) has advanced the specialty practice of nursing professional development for the enhancement of healthcare outcomes by providing access to education, experience, and resources targeting the various needs of nursing professional development team members. The organization's goal is to foster the acquisition and application of data-driven practices for the betterment of the NPD specialty, which is done by providing the education, tools, and resources to advance the ongoing professional and career development of members to ultimately promote population health.

During this year's ANPD Aspire Convention, which takes place April 9-12 in Chicago, Illinois, Wolters Kluwer will showcase a number of innovative products for the nursing education marketing including Ovid Synthesis and Lippincott Solutions. Additionally, the company will have several thought leaders and customers presenting on key topics, such as evidence-based practice's impact on improving outcomes.

For more information about Wolters Kluwer, please visit: www.wolterskluwer.com

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook (NASDAQ:META), YouTube and Instagram.

Josh DeStefano
Manager, External Communications
Wolters Kluwer Health
+1 (917) 408-5125
joshua.destefano@wolterskluwer.com

Source: Wolters Kluwer

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.